Poultry
xClose

Loading ...
Swine
xClose

Loading ...
Dairy & Ruminant
xClose

Loading ...
Aquaculture
xClose

Loading ...
Feed
xClose

Loading ...
Animal Health
xClose

Loading ...
Livestock Production
Friday, September 28, 2012 10:06:50 PM
Print this articleForward this article


Effect of active immunization against GnRH on testosterone concentration, libido and sperm quality in mature AI boars

  
Ronaldas Bilskis, Neringa Sutkeviciene, Vita Riskeviciene, Aloyzas Januskauskas and Henrikas Zilinskas
    
  
Background


The aim of the present study was to investigate the efficacy of the Improvac on testosterone concentration in blood serum, sexual behavior and sperm quality in matured AI boars. A total of nine Danish Landrace AI boars (http://www.efeedlink.com/search/?q=boars ) were included in the analysis.


Methods


The trial period lasted for 15 weeks and was divided into four periods: Control period: three weeks before vaccination; Period I - four weeks after first vaccination; Period II - four weeks after second vaccination, Period III - four weeks after third vaccination. Blood and sperm samples were collected at weekly intervals. Freshly collected sperm samples were analyzed.


Results


Testosterone concentration correlated with libido (r = 0.531; p < 0.001), volume of ejaculate (r = 0.324; p < 0.001) and the percentage of morphologically normal spermatozoa (r = 0.207; p < 0.05). Testosterone concentration rised significantly (p < 0.05) in 5-6 week of trial, e. i. after the first dose of Improvac and after this peak the level of testosterone further progressively decreased (p < 0.05).


Conclusions


Results from this study indicate that active immunization of sexually matured boars against GnRH has negative impact on testosterone concentration, sexual behavior, volume of ejaculate and total number of normal spermatozoa in ejaculate.

 


For more of the article, please click here.


Article made possible through the contribution of Ronaldas Bilskis, Neringa Sutkeviciene, Vita Riskeviciene, Aloyzas Januskauskas, Henrikas Zilinskas and BioMed Central.

Share this article on FacebookShare this article on TwitterPrint this articleForward this article
Previous
My eFeedLink last read